#psylocybine

  • Fungi, Folklore, and Fairyland – The Public Domain Review
    https://publicdomainreview.org/essay/fungi-folklore-and-fairyland

    « Mangez-moi, Mangez-moi
    C’est le chant du Psylo... »

    The first recorded mushroom trip in Britain took place in London’s Green Park on October 3, 1799. Like many such experiences before and since, it was accidental. A man identified in the subsequent medical report as “J. S.” was in the habit of gathering small field mushrooms from the park on autumn mornings and cooking them up into a breakfast broth for his wife and young family. But this particular morning, an hour after they had finished it, everything began to turn very strange. J. S. noticed black spots and odd flashes of colour interrupting his vision; he became disorientated and had difficulty in standing and moving around. His family were complaining of stomach cramps and cold, numb extremities. The notion of poisonous toadstools leapt to his mind, and he staggered out into the streets to seek help, but within a hundred yards he had forgotten where he was going, or why, and was found wandering in a confused state.

    By chance a physician named Everard Brande was passing through this part of town, and he was summoned to treat J. S. and his family. The scene he witnessed was so unusual that he wrote it up at length and published it in The Medical and Physical Journal a few months later.1 The family’s symptoms were rising and falling in giddy waves, their pupils dilated, their pulses fluttering, and their breathing laboured, periodically returning to normal before accelerating into another crisis. All were fixated on the fear that they were dying except for the youngest, the eight-year-old son named as “Edward S.”, whose symptoms were the strangest of all. He had eaten a large portion of the mushrooms and was “attacked with fits of immoderate laughter” which his parents’ threats could not subdue. He seemed to have been transported into another world, from which he would only return under duress to speak nonsense: “when roused and interrogated as to it, he answered indifferently, yes or no, as he did to every other question, evidently without any relation to what was asked”.

    Dr Brande diagnosed the family’s condition as the “deleterious effects of a very common species of agaric [mushroom], not hitherto suspected to be poisonous”. Today, we can be more specific: this was intoxication by liberty caps (Psilocybe semilanceata), the “magic mushrooms” that grow plentifully across the hills, moors, commons, golf courses, and playing fields of Britain every autumn. The botanical illustrator James Sowerby, who was working on the third volume of his landmark Coloured Figures of English Fungi or Mushrooms (1803), interrupted his schedule to visit J. S. and identify the species in question. Sowerby’s illustration includes a cluster of unmistakable liberty caps, together with a similar-looking species (now recognised as a roundhead of the Stropharia genus). In his accompanying note, Sowerby emphasises that it was the pointy-headed variety (“with the pileus acuminated”) that “nearly proved fatal to a poor family in Piccadilly, London, who were so indiscreet as to stew a quantity” for breakfast.

    Alors là, la ressemblance entre le bonnet phrygien et les psylos dans les champs... je ne l’avais encore jamais lue. Et la médaille de Benjamin franklin ne laisse pourtant aucun doute.

    During the nineteenth century, the liberty cap took on a different set of associations, derived not from its visionary properties but its distinctive appearance. Samuel Taylor Coleridge seems to have been the first to suggest its common name in a short piece published in 1812 in Omniana, a miscellany co-written with Robert Southey. Coleridge was struck by that “common fungus, which so exactly represents the pole and cap of Liberty that it seems offered by Nature herself as the appropriate emblem of Gallic republicanism”.3 The cap of Liberty, or Phrygian cap, a peaked felt bonnet associated with the similar-looking pileus worn by freed slaves in the Roman empire, had become an icon of political freedom through the revolutionary movements of the seventeenth and eighteenth centuries. William of Orange included it as a symbol on a coin struck to celebrate his Glorious Revolution in 1688; the anti-monarchist MP John Wilkes holds it, mounted on its pole, in William Hogarth’s devilish caricature of 1763. It appears on a medal designed by Benjamin Franklin to commemorate July 4, 1776, under the banner LIBERTAS AMERICANA, and it was adopted during the French Revolution by the sans-culottes as their signature bonnet rouge. It was these associations — rather than its psychoactive properties, of which he shows no knowledge — that led Coleridge to celebrate it as the “mushroom Cap of Liberty”, a name that percolated through the many reprints of Omniana into nineteenth-century British culture, folklore, and botany.

    In parallel to a growing scientific interest in toxic and hallucinogenic fungi, a vast body of Victorian fairy lore connected mushrooms and toadstools with elves, pixies, hollow hills, and the unwitting transport of subjects to fairyland, a world of shifting perspectives seething with elemental spirits. The similarity of this otherworld to those engendered by plant psychedelics in New World cultures, where psilocybin-containing mushrooms have been used for millennia, is suggestive. Is it possible that the Victorian fairy tradition, beneath its innocent exterior, operated as a conduit for a hidden tradition of psychedelic knowledge? Were the authors of these fantastical narratives — Alice in Wonderland, for example — aware of the powers of certain mushrooms to lead unsuspecting visitors to enchanted lands? Were they, perhaps, even writing from personal experience?

    Despite its ubiquity, and occasional and tentative association with nature spirits, the mushroom that became the distinctive motif of fairyland was not the liberty cap but rather the spectacular red-and-white fly agaric (Amanita muscaria). The fly agaric is psychoactive but unlike the liberty cap, which delivers psilocybin in reliable doses, it contains a mix of alkaloids — muscarine, muscimol, ibotenic acid — which generate an unpredictable and toxic cocktail of effects. These can include wooziness and disorientation, drooling, sweats, numbness in the lips and extremities, nausea, muscle twitches, sleep, and a vague, often retrospective sense of liminal consciousness and waking dreams. At lower doses, none of these may manifest; at higher doses they may lead to coma and, on rare occasions, death.

    Let us turn now to the most famous and frequently-debated conjunction of fungi, psychedelia, and fairy-lore: the array of mushrooms and hallucinatory potions, mind-bending and shapeshifting motifs in Alice’s Adventures in Wonderland (1865). Do Alice’s adventures represent first-hand knowledge of hallucinogenic mushrooms?

    The scenes in question could hardly be better known. Alice, down the rabbit hole, meets a caterpillar sitting on a mushroom, who tells her in a “languid, sleepy voice” that the mushroom is the key to navigating through her strange journey: “one side will make you grow taller, the other side will make you grow shorter”. Alice takes a chunk from each side of the mushroom and begins a series of vertiginous transformations of size, shooting up into the clouds before learning to maintain her normal size by eating alternate bites. Throughout the rest of the book she continues to take the mushroom: entering the house of the Duchess, approaching the domain of the March Hare, and, climactically, before entering the hidden garden with the golden key.

    Nevertheless, it seems unlikely that Alice’s mind-expanding journeys owed anything to the actual drug experiences of their author. Although Carroll — in daily life the Reverend Charles Dodgson — was a moderate drinker and, to judge by his library, opposed to alcohol prohibition, he had a strong dislike of tobacco smoking and wrote sceptically in his letters about the pervasive presence in syrups and soothing tonics of powerful narcotics like opium — the “medicine so dexterously, but ineffectually, concealed in the jam of our early childhood”.8 Yet Alice’s adventures may have their roots in a psychedelic mushroom experience. The scholar Michael Carmichael has demonstrated that, a few days before he began writing the story, Carroll made his only ever visit to Oxford’s Bodleian library, where a copy of Mordecai Cooke’s recently-published drug survey The Seven Sisters of Sleep (1860) had been deposited.9 The Bodleian copy of this book still has most of its pages uncut, with the exception of the contents page and the chapter on the fly agaric, entitled “The Exile of Siberia”. Carroll was particularly interested in Russia: it was the only country he ever visited outside Britain. And, as Carmichael puts it, Carroll “would have been immediately attracted to Cooke’s Seven Sisters of Sleep for two more obvious reasons: he had seven sisters and he was a lifelong insomniac”.

    If so, he was neither a secret drug initiate nor a Victorian gentleman entirely innocent of the arcane knowledge of drugs. In this sense, Alice’s otherworld experiences seem to hover, like much of Victorian fairy literature and fantasy, in a borderland between naïve innocence of such drugs and knowing references to them. We read them today from a very different vantage point, one in which magic mushrooms are consumed far more widely than in the Victorian or indeed any previous era. In our thriving psychedelic culture, fly agaric is only to be encountered at the distant margins; by contrast, psilocybin mushrooms are a global phenomenon, grown and consumed in virtually every country on earth and even making inroads into clinical psychotherapy. Today the liberty cap is an emblem of a new political struggle: the right to “cognitive liberty”, the free and legal alteration of one’s own consciousness.

    #Domaine_public #Champignons_hallucinogènes #Amanite_Tue-mouches #Psylocybine #Alice_au_pays_des_merveilles #Lewis_Caroll #Contes_de_fées

  • Psychedelic Mushrooms Are Closer to Medicinal Use (It’s Not Just Your Imagination) - The New York Times
    https://www.nytimes.com/2018/10/03/science/magic-mushrooms-psilocybin-scheduleiv.html

    Researchers from Johns Hopkins University have recommended that psilocybin, the active compound in hallucinogenic mushrooms, be reclassified for medical use, potentially paving the way for the psychedelic drug to one day treat depression and anxiety and help people stop smoking.

    The suggestion to reclassify psilocybin from a Schedule I drug, with no known medical benefit, to a Schedule IV drug, which is akin to prescription sleeping pills, was part of a review to assess the safety and abuse of medically administered psilocybin.

    Before the Food and Drug Administration can be petitioned to reclassify the drug, though, it has to clear extensive study and trials, which can take more than five years, the researchers wrote.

    The analysis was published in the October print issue of Neuropharmacology, a medical journal focused on neuroscience.

    For decades, though, researchers have shunned the study of psychedelics. “In the 1960s, they were on the cutting edge of neuroscience research and understanding how the brain worked,” Dr. Johnson said. “But then it got out of the lab.”

    Research stopped, in part, because the use of mind-altering drugs like LSD and mushrooms became a hallmark of hippie counterculture.

    The researchers who conducted the new study included Roland R. Griffiths, a professor in the departments of psychiatry and neurosciences at the Johns Hopkins University School of Medicine, who is one of the most prominent researchers on the behavioral and subjective effects of mood-altering drugs. The researchers reviewed data going back to the 1940s.

    Dr. Johnson said that the F.D.A. had approved a number of trials of psilocybin. If its use is approved for patients, he said, “I see this as a new era in medicine.”

    He added, “The data suggests that psychedelics are powerful behavioral agents.” In legal studies, he said, participants are given a capsule with synthetic psilocybin. (They are not given mushrooms to eat, which is how the drug is most often ingested.)

    He warned, though, that psilocybin is not a panacea for everyone. In their analysis, the researchers called for strict controls on its use. There are areas of risk, too, for patients with psychotic disorders and anyone who takes high doses of the drug.

    #Psychédéliques #Psylocybine #Champignons #Usage_médical #Pharmacie

  • Magic Mushrooms Fight Authoritarianism | Alternet
    https://www.alternet.org/drugs/magic-mushrooms-fight-authoritarianism-psilocybin-psychedelics

    Psychedelic drugs have been associated with anti-authoritarian counter-cultures since the 1960s, but a new study suggests using psilocybin, the psychedelic compound in magic mushrooms, actually makes people less likely to embrace authoritarian views, PsyPost reports. The study conducted by the Psychedelic Research Group at Imperial College London was published in the journal Psychopharmacology.

    While other studies have linked the use of psychedelics to a greater sense of oneness with nature, openness to new experiences and political and social liberalism, this is the first to provide experimental evidence their use can leading to lasting changes in these attitudes.

    In the study, researchers gave two oral doses of psilocybin to seven participants suffering from treatment-resistant major depression while a control group of seven healthy subjects did not receive psilocybin. Researchers surveyed participants about their political views and relationship to nature before the sessions, one week after the sessions, and 7-12 months later.

    Subjects who received the psilocybin treatment showed a significant decrease in authoritarian attitudes after treatment, and that reduction was sustained over time. They also reported a significant increase in a sense of relatedness to nature.

    "Before I enjoyed nature, now I feel part of it. Before I was looking at it as a thing, like TV or a painting… But now I see there’s no separation or distinction—you are it,” one participant told researchers.

    Subjects who had not received psilocybin did not exhibit significant changes in attitudes.

    #Psychédéliques #Psylocybine #Pharmacologie

  • Psychedelic Researcher: How Drugs Like LSD Can Change Your Life | Alternet
    http://www.alternet.org/drugs/psychedelic-researcher-how-drugs-lsd-can-change-your-life?akid=12803.10880

    The most cynical response I’ve received is: why would you pursue an area of research that doesn’t yet have federal funding? That’s a common response I get given the grant-focused nature of our positions. I understand that concern. … But I think there’s a sense among people doing this line of work that this could be such a game-changer that we owe it to ourselves, to humanity, to the field to pursue this kind of work whether that federal funding is there or not. … Obviously we would like to see that funding in the future because it’s necessary to run the sort of large-scale studies necessary to determine the efficacy of these substances. But I think for many of us this is a labor of love, and we’ll pursue this work without it.

    The idea here is that psychedelic-occasioned mystical experience can be life changing or transformative. You can use these substances just one time and experience what one of my favorite psychologists William Miller calls “quantum change”: the idea that someone can change very suddenly, very dramatically—and permanently. So the question is: could using these substances just one time have put you on the path to better mental health?

    AK: So this is a unique feature of psychedelics compared to other kinds of drugs? Nothing else has that kind of life-changing effect on people?

    PH: To the best of my knowledge, that’s correct. It is a unique characteristic of psychedelics, classic psychedelics in particular, to provide these sorts of experiences. There are examples of these transformative mystical experiences across the world’s great religions and in fiction. …The metaphysics of it are beyond my ability to comment on, but we know that these sort of life-changing experiences happen to people and they happen organically. And here we have a class of substances that can occasion this sort of transformative experience in a good percentage of those who use them. … What we found in our study is that those who’d used them were less likely to report psychological distress in the past month, and less likely to report suicidal thoughts, planning and attempts in the past year.

    PH: I think a key part of what were trying to do is change public opinion. It’s important for people to know that those of us who are working in this area are dispassionate scientists who are trying to study this in an objective manner. …We’re not interested in legalization or widespread use.

    If you really think about it, there’s nothing provocative about what we’re doing. We’re clinical scientists who would like to see the interventions we have be more effective. We’d like to see an alleviation of human suffering, and the scientific data would suggest that these substances might be very effective in that regard. It’s that simple. Were just pursuing a line of work that might make a real difference in terms of the pain that people have to endure. I would hope that everyone would agree with us in that regard, right? We’re trying to make the world a better place.